St. Louis School of Medicine: Antibiotic Doesn't Prevent Future Wheezing in Babies Hospitalized With RSV
February 28, 2022
February 28, 2022
ST. LOUIS, Missouri, Feb. 28 (TNSRes) -- The Washington University St. Louis School of Medicine issued the following news release:
The antibiotic azithromycin has anti-inflammatory properties that can be beneficial in some chronic lung diseases, such as cystic fibrosis. With that in mind, researchers investigated its potential to prevent future recurrent wheezing among infants hospitalized with respiratory syncytial virus (RSV). With such babies at increased risk of developing asthm . . .
The antibiotic azithromycin has anti-inflammatory properties that can be beneficial in some chronic lung diseases, such as cystic fibrosis. With that in mind, researchers investigated its potential to prevent future recurrent wheezing among infants hospitalized with respiratory syncytial virus (RSV). With such babies at increased risk of developing asthm . . .